Printer Friendly

Browse Movement disorders topic

Articles

1-221 out of 221 article(s)
Title Author Type Date Words
Dyskinesia - Pipeline Review, H2 2019. Dec 9, 2019 719
Review: Teleneurology Feasible for Several Neurologic Disorders; Benefits seen for management of dementia, epilepsy, MS, headache, movement disorders. Disease/Disorder overview Dec 4, 2019 258
Imaging in Movement Disorders: Imaging Applications in Non-Parkinsonian and Other Movement Disorders, Vol 143: International Review of Neurobiology. Nov 26, 2019 608
Primary Ciliary Dyskinesia Market 2019 Highlights, Industry Size, Top Key Players Growth Insights, Segment Analysis, Global Opportunity Status, Technology and Future Trends To 2023. Nov 25, 2019 692
Frequency of mirror movements and comparison of hand function in spastic cerebral palsy children with and without mirror movements. Javeria Shahid, Sheema Khan, Misbah Marryam and Imran Amjad Oct 31, 2019 3352
United States : Neurocrine Biosciences Presents New Data Analyses Demonstrating Long-Term Effects of INGREZZA 40 mg Once-Daily in Patients with Tardive Dyskinesia at the 2019 Annual Psych Congress. Oct 14, 2019 662
United States : Neurocrine Biosciences Presents New Data Analyses Demonstrating Long-Term Effects of INGREZZA (valbenazine) 40 mg Once-Daily in Patients with Tardive Dyskinesia at the 2019 Annual Psych Congress. Oct 7, 2019 672
United States : Neurocrine Biosciences to Present Data Analyses Demonstrating the Long-Term Effectiveness of INGREZZA (valbenazine) in Patients with Tardive Dyskinesia at the 2019 Annual Psych Congress. Oct 7, 2019 388
Neurocrine discloses results of Ingrezza study in tardive dyskinesia patients. Clinical report Oct 4, 2019 137
Psychosocial correlates of prolonged postpartum depression in mothers of children with movement disorders: cross-sectional study from a paediatric developmental rehabilitation centre in Peshawar. Report Sep 30, 2019 4333
United States : AbbVie to Present New and Updated Data From 22 Abstracts, Including Two Late-Breaking Abstracts for ABBV-951 and DUODOPA (levodopa/carbidopa intestinal gel), at the International Congress of Parkinson's Disease and Movement Disorders. Sep 28, 2019 411
Movement Disorder Market: An Insight On the Important Factors and Trends Influencing the Market. Sep 27, 2019 531
Agilik and NIH Sign Research Agreement to Evaluate Use of Wearable Exoskeleton to Improve Gait in Children with Movement Disorders. Sep 25, 2019 600
Active Biotech to present new data on laquinimod from the phase 2 LEGATO-HD study at the International congress of Parkinson's disease and movement disorders. Sep 24, 2019 237
Active Biotech to present new data on laquinimod from the phase 2 LEGATO-HD study at the International congress of Parkinson's disease and movement disorders. Sep 24, 2019 233
Mitsubishi Tanabe Pharma Corporation - Mitsubishi Tanabe Pharma Corporation Group Announces Presentation of Patient-Reported Results from Phase 2 ND0612 Study at International Congress of Parkinson's disease and Movement Disorders -- 23/9/2019. Sep 23, 2019 1026
Global Movement Disorder Market Projected to Witness Vigorous Expansion by 2017 to 2022. Sep 2, 2019 841
Global Movement Disorder Market Projected to Witness Vigorous Expansion by 2017 to 2022. Sep 2, 2019 854
Clinical Management of Binocular Vision: Heterophoric, Accommodative, and Eye Movement Disorders, 5th Edition (online access included). Book review Sep 1, 2019 135
Supply Of Material For The Treatment Of Neurological Diseases Of Movement Disorders By Deep Brain Stimulation For The San Carlos Clinical Hospital. Aug 27, 2019 111
Movement Disorder Market: Growing Demand to Impact Revenue Share during 2017-2022. Aug 7, 2019 836
Movement Disorder Market: Growing Demand to Impact Revenue Share during 2017-2022. Aug 7, 2019 823
Supply Of Material For The Treatment Of Neurological Diseases Of Movement Disorders Through Deep Brain Stimulation. Jul 17, 2019 123
CAPN1 Variants as Cause of Hereditary Spastic Paraplegia Type 76. Garcia-Berlanga, Jesus Eduardo; Moscovich, Mariana; Palacios, Isaac Jair; Banegas-Lagos, Alejandro; Jul 1, 2019 2065
Movement Disorder Market Set to Deliver Major Revenue Shares during the Forecast Period. Jun 28, 2019 865
Movement Disorder Market Set to Deliver Major Revenue Shares during the Forecast Period. Jun 27, 2019 878
Integral Approach Of The Patient With Movement Disorder And Special Needs Deep Cerebral Stimulation Of The Bellvitge University Hospital (hub) That Allows Their Treatment In The Most Efficient And Efficient Manner, Improving The Detection, Process, And Cl. Jun 13, 2019 182
Mixed Contract Regarding The Integral Approach Of Patients With Movement Disorder For Deep Brain Stimulation (ecp) Treatment. Jun 12, 2019 126
Treatment for Syndromes of Dementia and Movement Disorders Market 2019. May 20, 2019 359
Movement Disorder Market Forecast Based on Major Drivers & Trends Up to 2022. Mar 19, 2019 854
Trevi Therapeutics Inks License Agreements for use of Nalbuphine for the Treatment of Levodopa-Induced Dyskinesia in Parkinson's Disease. Feb 5, 2019 656
Soft Market Testing - Primary Ciliary Dyskinesia Management Service (adults). Feb 1, 2019 198
Soft Market Testing Primary Ciliary Dyskinesia Management Service (adults). Jan 31, 2019 172
Non-ketotic hyperglycaemia and the hemichorea-hemiballismus syndrome--a rare paediatric presentation. Hauptfleisch, M.P.K.; Rodda, J.L. Clinical report Dec 1, 2018 2014
Screening polytherapy patients might reduce movement disorders. Kling, Jim Report Dec 1, 2018 407
Global Movement Disorder Market Valuable Growth Prospects and Insights on Future Scenario till 2026. Nov 23, 2018 1213
Global Movement Disorder Market Valuable Growth Prospects and Insights on Future Scenario till 2026. Nov 22, 2018 1246
Global Movement Disorder Market Valuable Growth Prospects and Insights on Future Scenario till 2026. Nov 22, 2018 1232
INVITATION TO JOIN: The National Panel of Tardive Dyskinesia Expert Clinicans. Nasrallah, Henry A.; Yeiser, Bethany Report Nov 1, 2018 373
Abnormal subcortical activity in congenital mirror movement disorder with RAD51 mutation. Demirayak, Pinar; Onat, Onur Emre; Gevrekci, Aslihan Ors; Gulsuner, Suleyman; Uysal, Hilmi; Bilgen, Report Nov 1, 2018 4647
Ultragenyx announces Phase 3 study of UX007 did not achieve primary endpoint. Report Oct 26, 2018 314
United States : Acorda to Present Data for INBRIJA (levodopa inhalation powder) at International Congress of Parkinsons Disease and Movement Disorders. Oct 15, 2018 179
Vitamin B6 for tardive dyskinesia? Martone, Gerald Report Oct 1, 2018 1170
Treatment Syndromes Dementia Movement Disorders Market to Witness Steady Growth at 8.6% CAGR During. Sep 28, 2018 235
Expanding the Phenotype of Homozygous KCNMA1 Mutations; Dyskinesia, Epilepsy, Intellectual Disability, Cerebellar and Corticospinal Tract Atrophy. Yesil, Gozde; Aralasmak, Ayse; Akyiiz, Enes; Icagasioglu, Dilara; Sahin, Turkan Uygur; Bayram, Yavuz Report Aug 1, 2018 1738
United States : Adamas Presents New Data Analysis Demonstrating that GOCOVRI Reduces Transitions between Dyskinesia and OFF Episodes Throughout the Day. Jun 26, 2018 438
Adamas says new data shows GOCOVRI reduces transitions between dyskinesia, OFF. Jun 22, 2018 286
Re-examination of the Tremor Disability Scale-Revised (TREDS-R): A Case Control Comparison. Lundervold, Duane A.; Ament, Patrick A.; Holt, Peter S. Report Jun 1, 2018 3661
Nonketotic hyperglycemia-induced hemichorea-hemiballism. Cressman, Scott; Rheinboldt, Matt; Lin, David; Blase, John Case study Jun 1, 2018 1127
Recurrence of Sydenham's Chorea/Sydenham Koresi Rekurrensi. Tata, Gulten Letter to the editor Jun 1, 2018 1117
Revance says 'positive' Phase 2 RT002 study results published in journal. May 24, 2018 269
Herman Meinders Center for Movement Disorders opens. May 21, 2018 666
United States : Neurocrine Biosciences Presents New Data Analyses at AAN Annual Meeting Demonstrating INGREZZA Improved Tardive Dyskinesia Symptoms Across Body Regions. Apr 30, 2018 454
A Case of Dissociative Seizures Presented like Myoclonic Epilepsy. Reddy, Balaswamy; Das, Soumitra; Ali, Mustafa; Guruprasad, Srinivas Case study Apr 1, 2018 2539
Tardive dyskinesia: 5 Steps for prevention. Maestri, Thomas J. Report Apr 1, 2018 749
An Unusual Case of Megalencephalic Leukoencephalopathy Together with Giant Subcortical Cysts. Solmaz, Abdullah; Kazanasmaz, Halil; Calik, Mustafa Clinical report Apr 1, 2018 1064
United States : Adamas Announces Publication of Data Supporting the Benefits of GOCOVRI in Parkinson's Disease Patients with Dyskinesia. Mar 20, 2018 425
Adamas Pharmaceuticals' Govocri in dyskinesia featured in publication. Mar 15, 2018 137
Periodic limb movement disorder. Bloom, Patricia Feb 22, 2018 223
United States : Adamas Announces U.S. Commercial Launch of GOCOVRI the First and Only FDA-approved Medication for the Treatment of Dyskinesia in Parkinson's Disease Patients. Jan 12, 2018 294
Effect of Cathodal Transcranial Direct Current Stimulation on a Child with Involuntary Movement after Hypoxic Encephalopathy. Nagai, Mayumi; Tanaka, Naofumi; Oouchida, Yutaka; Izumi, Shin-Ichi Jan 1, 2018 2320
Cognitive Changes and Promotion in Parkinson's Disease. Wang, XiaoPing; Wang, XiJin; Chen, HaiBo; Canning, Sarah Duff; Luo, Xingguang Jan 1, 2018 901
Synaptic Plasticity Changes: Hallmark for Neurological and Psychiatric Disorders. Martella, Giuseppina; Bonsi, Paola; Johnson, Steven W.; Quartarone, Angelo Jan 1, 2018 1614
STUDY OF ADJUSTMENT IN PATIENTS WITH INVOLUNTARY MOVEMENT DISORDERS. Soorineedu, Rajendhar; Kumar P, Manoj; Sahithi J, Krishna; Sreekeerthi, Dasika Report Oct 30, 2017 4151
INSIGHTEC passes US FDA's approval to begin pivotal study of Exablate Neuro for the treatment of patients with Parkinson's Disease. Oct 26, 2017 244
INSIGHTEC passes US FDA's approval to begin pivotal study of Exablate Neuro for the treatment of patients with Parkinson's Disease. Oct 26, 2017 240
Deutetrabenazine for tardive dyskinesia. Meyer, Jonathan M. Report Oct 1, 2017 4077
A cross-sectional study on the characteristics of tardive dyskinesia in patients with chronic schizophrenia. Huang, Yanan; Pan, Lizhen; Teng, Fei; Wang, Geying; Li, Chenhu; Jin, Lingjing Report Oct 1, 2017 5463
Case of Neuroacanthocytosis Course With Neuropathy, Epilepsy and Choreiform Movement Disorder. Sonmez, Ali; Gol, Mehmet Fatih; Erdogan, Fusun Ferda Case study Sep 1, 2017 1990
Depression, anxiety, and quality of life in paroxysmal kinesigenic dyskinesia patients. Tian, Wo-Tu; Huang, Xiao-Jun; Liu, Xiao-Li; Shen, Jun-Yi; Liang, Gui-Ling; Zhu, Chen-Xi; Tang, Wei-G Report Sep 1, 2017 4433
ZAMBON - XADAGO[R] (SAFINAMIDE) NOW AVAILABLE IN THE U.S. FOR PARKINSON'S DISEASE PATIENTS -- 11/7/2017. Aug 25, 2017 668
ZAMBON - XADAGO[R] (SAFINAMIDE) NOW AVAILABLE IN THE U.S. FOR PARKINSON'S DISEASE PATIENTS -- 11/7/2017. Aug 18, 2017 667
Current Nondopaminergic Therapeutic Options for Motor Symptoms of Parkinson's Disease. Du, Juan-Juan; Chen, Sheng-Di Report Aug 5, 2017 8811
Clinicians, patients differ in perceptions of movement disorders. Moon, Mary Ann Aug 1, 2017 300
Safety for a child with a severe movement disorder. Rosen, Luke Jul 1, 2017 979
Movement disorder and epilepsy in subependymal nodular heterotopia. Lohmror, Anurag; Choudhary, Richa Case study Jul 1, 2017 1907
The role of the scapular dyskinesis in shoulder disorders/IL RUOLO DELLA DISCINESIA SCAPOLARE NELLE PATOLOGIE DI SPALLA. Zanetti, Elisa; Ristori, Diego; Miele, Simone; Testa, Marco Jul 1, 2017 19188
Osteonecrosis in the both femoral heads in a patient with Neuro-Behcet's Disease. Jun 30, 2017 1259
United States : Adamas Announces Publication of ADS-5102 Phase 3 EASE LID Clinical Trial in JAMA Neurology. Jun 17, 2017 684
United States : Adamas Presents Expanded Analysis from the ADS-5102 Open-Label Study Showing Tolerability and Durability out to 88 Weeks. Jun 10, 2017 576
United States : Neurocrine Announces Presentations Related to INGREZZA (valbenazine) Capsules at the 21st International Congress of Parkinson's Disease and Movement Disorders. Jun 3, 2017 148
Israel : Teva to Present Data from 18 Abstracts in Tardive Dyskinesia and Huntington Disease at the 21st International Congress of Parkinsons Disease and Movement Disorders. Jun 2, 2017 1070
Non epileptic paroxysmal events in childhood. Tatli, Burak; Guler, Serhat Report Jun 1, 2017 4924
Gotta catch 'em all: is Pokemon Go an intervention? Dotinga, Randy May 1, 2017 822
United States : Adamas Presents ADS-5102 Pooled Phase 3 Data Confirming Statistically Significant Reduction in Levodopa-Induced Dyskinesia and OFF Time in People with Parkinson's Disease. Apr 29, 2017 456
Israel,United States : Teva Announces Publication of ARM-TD Study Results in Neurology for the Investigational Use of Deutetrabenazine in Tardive Dyskinesia. Apr 29, 2017 184
United States : Neurocrine announces FDA approval of INGREZZA TM (valbenazine) capsules as the first and only approved treatment for adults with Tardive Dyskinesia (TD). Apr 13, 2017 526
Satisfaction and occupational performance in patients with functional movement disorder. Dahlhauser, Sarah E.; Theuer, Amanda; Hollman, John Report Mar 22, 2017 2816
Teva wins US FDA's priority review for SD-809 for tardive dyskinesia. Mar 1, 2017 217
Teva wins US FDA's priority review for SD-809 for tardive dyskinesia. Mar 1, 2017 213
Adamas Pharmaceuticals' NDA for ADS-5102 for levodopa-induced dyskinesia (LID) in patients with Parkinson's disease submitted for US FDA review. Jan 9, 2017 328
Adamas Pharmaceuticals' NDA for ADS-5102 for levodopa-induced dyskinesia (LID) in patients with Parkinson's disease submitted for US FDA review. Jan 9, 2017 324
Neurocrine Biosciences's NDA for INGREZZA for tardive dyskinesia awarded US FDA's PDUFA) target action date of 11 April 2017. Jan 6, 2017 271
Neurocrine Biosciences's NDA for INGREZZA for tardive dyskinesia awarded US FDA's PDUFA) target action date of 11 April 2017. Jan 6, 2017 267
The Relationship between Locomotive Syndrome and Depression in Community-Dwelling Elderly People. Nakamura, Misa; Hashizume, Hiroshi; Nomura, Sachiko; Kono, Ryohei; Utsunomiya, Hirotoshi Report Jan 1, 2017 4056
Anthropometric Measures and Frailty Prediction in the Elderly: An Easy-to-Use Tool. Closs, Vera Elizabeth; Ziegelmann, Patricia Klarmann; Flores, Joao Henrique Ferreira; Gomes, Irenio; Report Jan 1, 2017 6645
Predicting the Types of Ion Channel-Targeted Conotoxins Based on AVC-SVM Model. Xianfang, Wang; Junmei, Wang; Xiaolei, Wang; Yue, Zhang Report Jan 1, 2017 4966
SOX5-Null Heterozygous Mutation in a Family with Adult-Onset Hyperkinesia and Behavioral Abnormalities. Zech, Michael; Poustka, Katharina; Boesch, Sylvia; Berutti, Riccardo; Strom, Tim M.; Grisold, Wolfga Clinical report Jan 1, 2017 3626
Hemiataxia: A Novel Presentation of Anti-NMDA Receptor Antibody Mediated Encephalitis in an Adolescent. Phillips, Greg D.; Jones, Gillian N.; Callaghan, Maureen; DiFazio, Marc P. Jan 1, 2017 2842
A Case of Sporadic Creutzfeldt-Jakob Disease Presenting as Conversion Disorder. Yegya-Raman, Nikhil; Aziz, Rehan; Schneider, Daniel; Tobia, Anthony; Leitch, Megan; Nwobi, Onyi Jan 1, 2017 2717
Programming for Stimulation-Induced Transient Nonmotor Psychiatric Symptoms after Bilateral Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease. Wu, Xi; Qiu, Yiqing; Simfukwe, Keith; Wang, Jiali; Chen, Jianchun; Hu, Xiaowu Report Jan 1, 2017 7193
The Level of Knowledge of Parkinson's Disease among Nonprofessional Caregivers in a Movement Disorders Center in Turkey. Gultekin, Murat; Sanlar, Ayse Caglar; Ekinci, Ayten; Erturk, Gozde; Mirza, Meral Report Jan 1, 2017 2744
Deep Brain Stimulation in Parkinson's Disease: New and Emerging Targets for Refractory Motor and Nonmotor Symptoms. Anderson, Dustin; Beecher, Grayson; Ba, Fang Report Jan 1, 2017 9176
Antidyskinetic Treatment with MTEP Affects Multiple Molecular Pathways in the Parkinsonian Striatum. Lin, Jing-ya; Liu, Zhen-guo; Xie, Cheng-Long; Song, Lu; Yan, Ai-Juan Report Jan 1, 2017 5520
Association of Gait Characteristics and Depression in Patients with Parkinson's Disease Assessed in Goal-Directed Locomotion Task. Kincses, Peter; Kovacs, Norbert; Karadi, Kazmer; Feldmann, Adam; Dorn, Krisztina; Aschermann, Zsuzsa Report Jan 1, 2017 4946
Mitochondrial Respiration in Intact Peripheral Blood Mononuclear Cells and Sirtuin 3 Activity in Patients with Movement Disorders. Michalak, Slawomir; Florczak-Wyspianska, Jolanta; Rybacka-Mossakowska, Joanna; Ambrosius, Wojciech; Jan 1, 2017 7444
Tongluo Zhitong Prescription Alleviates Allodynia, Hyperalgesia, and Dyskinesia in the Chronic Constriction Injury Model of Rats. Wang, Zhiyong; Wang, Jianwei; Qin, Lihua; Zhang, Weiguang Jan 1, 2017 3523
Neurocrine announces review of INGREZZA NDA for tardive dyskinesia by US FDA's Psychopharmacologic Drugs Advisory Committee. Nov 30, 2016 259
Neurocrine announces review of INGREZZA NDA for tardive dyskinesia by US FDA's Psychopharmacologic Drugs Advisory Committee. Nov 30, 2016 255
Israel : Teva announces Positive Top-Line Data from Second Phase III Study of SD-809 in Tardive Dyskinesia (TD). Sep 23, 2016 644
Functional neurosurgery (part 2). Enslin, J.M.N. Guest editorial Sep 1, 2016 575
Surgical management of movement disorders. Enslin, J.M.N. Report Sep 1, 2016 3214
Mutation Analysis of MR-1, SLC2A1, and CLCN1 in 28 PRRT2-negative Paroxysmal Kinesigenic Dyskinesia Patients. Wang, Hong-Xia; Li, Hong-Fu; Liu, Gong-Lu; Wen, Xiao-Dan; Wu, Zhi-Ying Report Sep 1, 2016 3215
Neurocrine submits NDA for once-daily dosing of valbenazine for treating tardive dyskinesia. Aug 30, 2016 261
Neurocrine submits NDA for once-daily dosing of valbenazine for treating tardive dyskinesia. Aug 30, 2016 257
Jitter values on voluntary active periocular muscles of healthy subjects with conventional (37 mm) concentric needle electrode. Kirac, Leyla Baysal; Orhan, Elif Kocasoy; Gonderten, Saygin; Baslo, Mehmet Baris; Oge, Ali Emre Report Jun 1, 2016 2317
Withdrawal-emergent dyskinesia and supersensitivity psychosis due to olanzapine use. Karas, Hakan; Guduk, Mehmet; Saatcioglu, Omer Report Jun 1, 2016 1615
Dyskinesia - Pipeline Review, H1 2016 - New Market Study Published. Report May 2, 2016 481
The star athlete: moving our daughter from a frail little girl who couldn't open a car door to an all-star athlete did not happen overnight. Grafwallner, Peg May 1, 2016 1799
Role of magnetic resonance imaging in the diagnosis of adult onset movement disorders. Ankireddy, Padmaja; Tummala, Nageswara Rao; Donepudi, Haritha; Shaik, Afsar Pasha; Tummala, Rajeswar Report Mar 31, 2016 2651
The effect of hyperhomocysteinemia on motor symptoms, cognitive status, and vascular risk in patients with Parkinson's disease. Kocer, Bilge; Guven, Hayat; Conkbayir, Isik; Comoglu, Selim Selcuk; Delibas, Sennur Report Jan 1, 2016 5048
Foetal cell transplantation for Parkinson's disease: focus on graft-induced dyskinesia. Tronci, Elisabetta; Fidalgo, Camino; Carta, Manolo Jan 1, 2016 5374
Characteristics of nonmotor symptoms in progressive supranuclear palsy. Ou, Ruwei; Song, Wei; Wei, Qianqian; Chen, Ke; Cao, Bei; Hou, Yanbing; Zhao, Bi; Shang, Huifang Report Jan 1, 2016 5313
Pathophysiology of motor dysfunction in Parkinson's disease as the rationale for drug treatment and rehabilitation. Magrinelli, Francesca; Picelli, Alessandro; Tocco, Pierluigi; Federico, Angela; Roncari, Laura; Sman Report Jan 1, 2016 14024
New Market Research Report: Dyskinesia - Pipeline Review, H2 2015. Nov 2, 2015 427
Tardive Dyskinesia - Pipeline Review, H2 2015 - New Study Released. Sep 22, 2015 415
Amarantus BioScience Holdings doses first patient in Phase 2b clinical study of eltoprazine for treating Parkinson's disease levodopa-induced dyskinesia. Clinical report Jul 21, 2015 296
Amarantus BioScience Holdings doses first patient in Phase 2b clinical study of eltoprazine for treating Parkinson's disease levodopa-induced dyskinesia. Clinical report Jul 21, 2015 292
Intra and inter-rater reliability of screening for movement impairments: movement control tests from the foundation matrix. Mischiati, Carolina R.; Comerford, Mark; Gosford, Emma; Swart, Jacqueline; Ewings, Sean; Botha, Nadi Report Jun 1, 2015 11694
New Market Report: Dyskinesia - Pipeline Review, H1 2015. Apr 29, 2015 426
New Market Research Report: Dyskinesia Global Clinical Trials Review, H1, 2015. Apr 19, 2015 432
New Market Report: Tardive Dyskinesia - Pipeline Review, H1 2015. Mar 3, 2015 417
Global Treatment for Syndromes of Dementia and Movement Disorders Market Will Reach US $21,154.8 Million in 2020 by Persistence Market Research. Dec 17, 2014 689
Kartagener's syndrome. Gadappa, Swati M.; Bakliwal, Anamika Nov 10, 2014 1304
Paliperidone induced tardive dyskinesia: case reports. Ravani, Niraj; Jadhav, Sanjay Oct 20, 2014 811
Hand stiffness following distal radius fractures: who gets it and is it a functional problem? Egol, Kenneth A.; Karia, Raj; Zingman, Allissa; Lee, Steve; Paksima, Nader Report Oct 1, 2014 4224
Biliary pain, no gallstones--remove the gallbladder, anyway? As these 2 cases show, cholecystectomy may be helpful for such patients, even those with a high ejection fraction. Case study Aug 1, 2014 1266
Progressive Impairment of Motor Skill Learning in a D-Galactose- Induced Aging Mouse Model. Ma, Keshi; Wu, Anquan; Yang, Tongwen; Sheng, Dongfeng; Chen, Long; Li, Lili; Liu, Kun Report Feb 28, 2014 3702
Effect of Zishenpingchan granule on neurobehavioral manifestations and the activity and gene expression of striatal dopamine D1 and D2 receptors of rats with levodopa-induced dyskinesias. Ye, Qing; Yuan, Xiao-Lei; Zhou, Jie; Yuan, Can-xing; Yang, Xu-ming Report Jan 1, 2014 7582
Alterations of Eye Movement Control in Neurodegenerative Movement Disorders. Gorges, Martin; Pinkhardt, Elmar H.; Kassubek, Jan Report Jan 1, 2014 9118
Current Concepts in the Classification and Diagnosis of Frontotemporal Lobar Degenerations: A Practical Approach. Rohan, Zdenek; Matej, Radoslav Jan 1, 2014 5018
Chorea-ballismus associated with hyperglycemia/ Hiperglisemi ile iliskili kore-ballismus. Orhan, Elif Kocasoy; Atmaca, M. Mert; Atmaca, Melek; Hanagasi, Hasmet A. Clinical report Dec 1, 2013 2479
Low vitamin D associated with physical limitations. Brief article Nov 1, 2013 115
Movement disorders in neurologic disease; effects on communication and swallowing. Book review Oct 1, 2013 103
Dyskinesia Global Clinical Trials Review, H1, 2013 - New Report Available. Apr 30, 2013 406
Behavioral Relaxation Training for Parkinson's Disease Related Dyskinesia and Comorbid Social Anxiety. Lundervold, Duane A.; Pahwa, Rajesh; Lyons, Kelly E. Report Jan 1, 2013 3796
Upper extremity freezing and Dyscoordination in Parkinson's disease: effects of amplitude and cadence manipulations. Williams, April J.; Peterson, Daniel S.; Ionno, Michele; Pickett, Kristen A.; Earhart, Gammon M. Report Jan 1, 2013 5367
The current state and needs of North American movement disorders fellowship programs. Shih, Ludy C.; Tarsy, Daniel; Okun, Michael S. Report Jan 1, 2013 3407
Modification of the ladder rung walking task--new options for analysis of skilled movements. Antonow-Schlorke, Iwa; Ehrhardt, Julia; Knieling, Marcel Report Jan 1, 2013 7627
Resveratrol could help maintain senior mobility. Dye, D. Report Dec 1, 2012 218
Neurocrine Biosciences Inc reports launch of Phase IIb study of NBI-98854 for Tardive Dyskinesia. Clinical report Oct 2, 2012 199
Neurocrine Biosciences Inc reports launch of Phase IIb study of NBI-98854 for Tardive Dyskinesia. Clinical report Oct 2, 2012 195
Movement disorders; unforgettable cases and lessons from the bedside. Brief article Oct 1, 2012 121
Common movement disorders pitfalls; case-based learning. (DVD-ROM included). Book review Aug 1, 2012 125
Antecedents of locomotor disorders in wild animals and its impact--an insight. Chhangani, Anil Kumar Report Jul 1, 2012 3436
Micrographia. Letter to the editor May 1, 2012 243
Q/What drugs are effective for periodic limb movement disorder? Lee, Yuri A.; Huynh, Philip; Neher, Jon O.; Safranek, Sarah May 1, 2012 1251
How best to address these common movement disorders: this review describes how to manage everything from Parkinson's disease and tic disorders to restless legs syndrome and ataxia. Yaman, Aylin; Akdeniz, Melahat; Yaman, Hakan Report Dec 1, 2011 3027
Researchers use iPS cells to decode perplexing movement disorder. Disease/Disorder overview Nov 28, 2011 539
YouTube videos can inaccurately depict movement disorders. Sep 22, 2011 256
Abbott reports interim Phase III study results for Parkinson's disease treatment. Jun 10, 2011 406
Pregnant and moving involuntarily: after ms. a delivers a preterm girl, the obstetrics service notes she has a blunted affect and involuntary movement of the arms and legs. What could be causing her symptoms? Schwartz, Ann C.; Lawley, Megan Clinical report Jun 1, 2011 2913
Safinamide plus levodopa reduced dyskinesia. Brunk, Doug May 1, 2011 540
Potential of robots as next-generation technology for clinical assessment of neurological disorders and upper-limb therapy. Scott, Stephen H.; Dukelow, Sean P. Report Apr 1, 2011 12189
Care of the movement disorder patient with a deep brain stimulator. Ward, Constance; Heath, Susan; Janovsky, Virginia; Lanier, Elaine; Franks, Romay; O'Connor, Susan Report Apr 1, 2011 402
The mechanics of human mobility. Thilmany, Jean Apr 1, 2011 323
Movement disorder management for all specialties. Hogan, Patrick J., III Disease/Disorder overview Jan 1, 2011 1413
Treatment of tremor with botulinum toxin/Tremor tedavisinde botulinum toksini. Tokcaer, Ayse Bora Report Dec 1, 2010 3391
Mobility decline in PAD patients depends on symptoms. Brief article Sep 1, 2010 168
Complete ciliary aplasia; a rare form of primary ciliary dyskinesia / Komplet silier aplazi; primer silier diskinezinin nadir formu. Ergun, Pinar; Deniz, Pelin Pinar; Erdogan, Yurdanur; Turay, Ulku Yilmaz; Biber, Cigdem; Ciftci, Bule Sep 1, 2010 2012
Identifying movement patterns and severity of associated pain in sign language interpreters. Freeman, Julie K.; Rogers, Janet L. Report Jun 1, 2010 2480
Nonmotor effects rise in importance. Hallett, Mark Brief article May 15, 2010 264
Irregular arm swing may point to Parkinson's disease. Mar 22, 2010 452
Retailers can provide solutions for mobility problems. Johnston, Jennifer Mar 15, 2010 657
Movement Disorders Sourcebook, second edition. Book review Aug 1, 2009 80
Mobility's economic impact. Brief article Jul 1, 2009 232
In patients with chronic stroke and impaired hand movements, electrical somatosensory stimulation (ESS) of the median nerve of the affected hand appears to enhance motor function, according to results of a small study conducted in Germany. Brief article Jun 8, 2009 288
Movement disorders and MDMA abuse. Wilcox, James Allen; Wilcox, Aidee Herrera Report Jun 1, 2009 1431
Revisions needed to streamline diagnostic criteria for PMDs. Evans, Jeff Report May 1, 2009 574
Metoclopramide to carry stronger dyskinesia warning. Mechcatie, Elizabeth Apr 1, 2009 316
Stronger dyskinesia warning required for Metoclopramide. Mechcatie, Elizabeth Apr 1, 2009 354
Stronger warning on dyskinesia risk required on metoclopramide. Mechcatie, Elizabeth Mar 15, 2009 429
Recognize the signs of peripheral arterial disease: it's a common disorder that affects mobility but also raises your cardiovascular risk. Mar 1, 2009 726
Factors predicting walking intolerance in patients with peripheral arterial disease and intermittent claudication. Parr, B.; Noakes, T.D.; Derman, E.W. Report Dec 1, 2008 3437
Peripheral arterial disease: predicting walking intolerance. Brief article Dec 1, 2008 148
Evaluation of electromagnetic incompatibility concerns for deep brain stimulators. Dustin, Kelly Oct 1, 2008 3783
Movement disorders: things that do go bump in the night. Barnhill, Jarrett; Hurley, Anne D. Report Oct 1, 2008 2958
Hypermobility increases risk of osteoporosis. Napoli, Denise Jun 15, 2008 837
Use it or lose it: staying active can help prevent disability: recent research shows that inactivity can lead to a loss of mobility later in life. Jun 1, 2008 412
Sorry guys, this drug reduces senior moments in women only. Apr 1, 2008 955
Lively limbs limit, disrupt sleep time for elders. Splete, Heidi Mar 15, 2008 630
Integrated electromyogram and eye-gaze tracking cursor control system for computer users with motor disabilities. Chin, Craig A.; Barreto, Armando; Cremades, J. Gualberto; Adjouadi, Malek Report Jan 1, 2008 8593
Reading, why not? Literacy skills in children with motor and speech impairments. Ferreira, Janna; Ronnberg, Jerker; Gustafson, Stefan; Wengelin, Asa Report Jun 22, 2007 11393
Virtual cues and functional mobility of people with Parkinson's disease: a single-subject pilot study. Kaminsky, Tatiana A.; Dudgeon, Brian J.; Billingsley, Felix F.; Mitchell, Pamela H.; Weghorst, Suzan Report May 1, 2007 5505
Therapeutic exercise in physiotherapy practice is beneficial: a summary of systematic reviews 2002-2005. Taylor, Nicholas F.; Dodd, Karen J.; Shields, Nora; Bruder, Andrea Report Mar 1, 2007 8000
Movement deficits in Parkinson's disease and restorative occupational therapy. Shah, Surya; Nolen, Ann Sep 1, 2006 6840
Impulsive behavior found common in Parkinson's: Reward-based behaviors were more likely in patients taking combinations of medications for their disease. Bates, Betsy Jan 15, 2006 590
Nursing time to program and assess deep brain stimulators in movement disorder patients. Hunka, Karen; Suchowersky, Oksana; Wood, Susan; Derwent, Lorelei; Kiss, Zelma H.T. Aug 1, 2005 3731
Recent developments in the therapeutic potential of cannabinoids. Corey, Susan Mar 1, 2005 6015
Hypermobility, limb pain shouldn't limit activity. Bates, Betsy Oct 1, 2004 501
West Nile prognosis linked to clinical symptoms: neurologic manifestations. Bates, Betsy Sep 1, 2003 791
The West Nile virus presentation is changing for the worse: neurologic manifestations. Bates, Betsy Sep 1, 2003 749
Physiotherapy for people with movement disorders arising from basal ganglia dysfunction. Bilney, Belinda; Morris, Meg E.; Denisenko, Sonia Jul 1, 2003 6696
Freedom concepts. (Mobility: Special Advertising Section). Brief Article May 1, 2003 217
Update on the treatment of childhood movement disorders. (Special Report). Kirkland, Anne May 1, 2002 7345
Focus on pediatric movement disorders: myoclonus. (ask the doctor). Sanger, Terence D.; Bartnett, Joy E. Mar 1, 2002 2206
Focus on pediatric movement disorders: ataxia. (ask the doctor). Sanger, Terence; Bartnett, Joy E. Dec 1, 2001 1573
Neurosurgery for Movement Disorders. Tornqvist, Anna Lena Apr 1, 2001 2926
Hypokinetic Movement Disorders. Borrell, Ellie Oct 1, 2000 1379
The Experience of Disease: Psychosocial Aspects of Movement Disorders. Jacopini, Gioia Oct 1, 2000 2021
MICHAEL J. FOX'S CHALLENGING NEW ROLE. Perry, Patrick Interview Sep 1, 2000 3367
PARKINSON'S DISEASE--THE SEARCH FOR GENETIC CLUES. Perry, Patrick Sep 1, 2000 1784
Parkinson's Disease Revisited. Herndon, Christopher M.; Young, Katherine; Herndon, Angela D.; Dole, Ernest J. Aug 1, 2000 4057
Fall Risk Factors in Parkinson's Disease. Gray, Peggy; Hildebrand, Kathleen Statistical Data Included Aug 1, 2000 4617
PARKINSON'S DISEASE--THE SEARCH FOR GENETIC CLUES. Perry, Patrick Interview May 1, 2000 1648
WE MOVE International Guide to Movement Disorder Organizations and Foundations. Directory Jan 1, 1999 5728
"We Move" - increasing awareness of movement disorders. Jul 1, 1998 1040
Hypotonia; gastrointestinal problems. Hirsch, David Apr 1, 1995 861
Does strep trigger movement disorders? Fackelmann, Kathy A. Jul 17, 1993 590
Clumsiness years later. Jun 1, 1991 186
Neuroleptic backlash. Bower, Bruce Jul 20, 1985 1204

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters